Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 502

1.

Integration of target analyses, non-target screening and effect-based monitoring to assess OMP related water quality changes in drinking water treatment.

Brunner AM, Bertelkamp C, Dingemans MML, Kolkman A, Wols B, Harmsen D, Siegers W, Martijn BJ, Oorthuizen WA, Ter Laak TL.

Sci Total Environ. 2019 Nov 27:135779. doi: 10.1016/j.scitotenv.2019.135779. [Epub ahead of print]

PMID:
31818566
2.

Increased mitochondrial apoptotic priming with targeted therapy predicts clinical response to re-induction chemotherapy.

Garcia JS, Bhatt S, Fell G, Sperling AS, Burgess M, Keshishian H, Yilma B, Brunner A, Neuberg D, Carr SA, Ebert BL, Ballen K, Stone RM, DeAngelo DJ, Medeiros BC, Letai A.

Am J Hematol. 2019 Dec 5. doi: 10.1002/ajh.25692. [Epub ahead of print]

PMID:
31804723
3.

Proteomics-Based Comparative Mapping of the Secretomes of Human Brown and White Adipocytes Reveals EPDR1 as a Novel Batokine.

Deshmukh AS, Peijs L, Beaudry JL, Jespersen NZ, Nielsen CH, Ma T, Brunner AD, Larsen TJ, Bayarri-Olmos R, Prabhakar BS, Helgstrand C, Severinsen MCK, Holst B, Kjaer A, Tang-Christensen M, Sanfridson A, Garred P, Privé GG, Pedersen BK, Gerhart-Hines Z, Nielsen S, Drucker DJ, Mann M, Scheele C.

Cell Metab. 2019 Nov 5;30(5):963-975.e7. doi: 10.1016/j.cmet.2019.10.001. Epub 2019 Oct 24.

PMID:
31668873
4.

Evaluation criteria for the assessment of occupational diseases of the lumbar spine - how reliable are they?

Ulmar B, Wölfle-Roos J, Kocak T, Brunner A.

BMC Musculoskelet Disord. 2019 Oct 27;20(1):485. doi: 10.1186/s12891-019-2878-4.

5.

Three-dimensional computed tomography reconstruction improves the reliability of tibial pilon fracture classification and preoperative surgical planning.

Keiler A, Riechelmann F, Thöni M, Brunner A, Ulmar B.

Arch Orthop Trauma Surg. 2019 Sep 16. doi: 10.1007/s00402-019-03259-8. [Epub ahead of print]

PMID:
31529150
6.

Need for concomitant Akin osteotomy in patients undergoing Chevron osteotomy can be determined preoperatively: a retrospective comparative study of 859 cases.

Kaufmann G, Hofmann M, Braito M, Ulmer H, Brunner A, Dammerer D.

J Orthop Surg Res. 2019 Aug 28;14(1):277. doi: 10.1186/s13018-019-1319-2.

7.

Acute Myeloid Leukemia: A New Era of Therapies, a New Wave of Toxicities?

Brunner AM.

Acta Haematol. 2019 Jul 17:1-2. doi: 10.1159/000501330. [Epub ahead of print] No abstract available.

8.

Outcomes for older adults with acute myeloid leukemia after an intensive care unit admission.

Slavin SD, Fenech A, Jankowski AL, Abel GA, Brunner AM, Steensma DP, Fathi AT, DeAngelo DJ, Wadleigh M, Hobbs GS, Amrein PC, Stone RM, Temel JS, El-Jawahri A.

Cancer. 2019 Nov 1;125(21):3845-3852. doi: 10.1002/cncr.32397. Epub 2019 Jul 12.

PMID:
31299106
9.

Features of schizophrenia following premorbid eating disorders.

Malaspina D, Walsh-Messinger J, Brunner A, Rahman N, Corcoran C, Kimhy D, Goetz RR, Goldman SB.

Psychiatry Res. 2019 Aug;278:275-280. doi: 10.1016/j.psychres.2019.06.035. Epub 2019 Jun 21.

PMID:
31254876
10.

Multicenter analysis of outcomes in blastic plasmacytoid dendritic cell neoplasm offers a pretargeted therapy benchmark.

Taylor J, Haddadin M, Upadhyay VA, Grussie E, Mehta-Shah N, Brunner AM, Louissaint A Jr, Lovitch SB, Dogan A, Fathi AT, Stone RM, Tallman MS, Rampal RK, Neuberg DS, Stevenson KE, Horwitz SM, Lane AA.

Blood. 2019 Aug 22;134(8):678-687. doi: 10.1182/blood.2019001144. Epub 2019 Jun 26.

PMID:
31243042
11.

Cardiac and genetic predictors of cardiovascular risk in patients with myelodysplastic syndromes.

Chen EC, Werner L, Hobbs GS, Narayan R, Amrein PC, Fathi AT, Brunner AM.

Leuk Lymphoma. 2019 Dec;60(12):3058-3062. doi: 10.1080/10428194.2019.1617863. Epub 2019 May 23. No abstract available.

PMID:
31120366
12.

Allogeneic hematopoietic cell transplantation improves outcome of adults with t(6;9) acute myeloid leukemia - results from an international collaborative study.

Kayser S, Hills RK, Luskin MR, Brunner AM, Terré C, Westermann J, Menghrajani K, Shaw C, Baer MR, Elliott MA, Perl AE, Ráčil Z, Mayer J, Zak P, Szotkowski T, de Botton S, Grimwade D, Mayer K, Walter RB, Krämer A, Burnett AK, Ho AD, Platzbecker U, Thiede C, Ehninger G, Stone RM, Röllig C, Tallman MS, Estey EH, Müller-Tidow C, Russell NH, Schlenk RF, Levis MJ.

Haematologica. 2019 Apr 19. pii: haematol.2018.208678. doi: 10.3324/haematol.2018.208678. [Epub ahead of print]

13.

TV vs. YouTube: TV Advertisements Capture More Visual Attention, Create More Positive Emotions and Have a Stronger Impact on Implicit Long-Term Memory.

Weibel D, di Francesco R, Kopf R, Fahrni S, Brunner A, Kronenberg P, Lobmaier JS, Reber TP, Mast FW, Wissmath B.

Front Psychol. 2019 Mar 21;10:626. doi: 10.3389/fpsyg.2019.00626. eCollection 2019.

14.

Populus trichocarpa clade A PP2C protein phosphatases: their stress-induced expression patterns, interactions in core abscisic acid signaling, and potential for regulation of growth and development.

Rigoulot SB, Petzold HE, Williams SP, Brunner AM, Beers EP.

Plant Mol Biol. 2019 Jun;100(3):303-317. doi: 10.1007/s11103-019-00861-7. Epub 2019 Apr 3.

PMID:
30945147
15.

Quality of life and mood of older patients with acute myeloid leukemia (AML) receiving intensive and non-intensive chemotherapy.

El-Jawahri A, Abel GA, Traeger L, Waldman L, Markovitz N, VanDusen H, Fathi A, Steensma DP, LeBlanc TW, Horick NK, DeAngelo DJ, Wadleigh M, Hobbs G, Foster J, Brunner AM, Amrein P, Stone RM, Temel JS, Greer JA.

Leukemia. 2019 Oct;33(10):2393-2402. doi: 10.1038/s41375-019-0449-1. Epub 2019 Mar 28.

PMID:
30923318
16.

NADPH oxidase 4 expression in the normal endometrium and in endometrial cancer.

Degasper C, Brunner A, Sampson N, Tsibulak I, Wieser V, Welponer H, Marth C, Fiegl H, Zeimet AG.

Tumour Biol. 2019 Feb;41(2):1010428319830002. doi: 10.1177/1010428319830002.

PMID:
30813866
17.

Site-specific ubiquitylation and SUMOylation using genetic-code expansion and sortase.

Fottner M, Brunner AD, Bittl V, Horn-Ghetko D, Jussupow A, Kaila VRI, Bremm A, Lang K.

Nat Chem Biol. 2019 Mar;15(3):276-284. doi: 10.1038/s41589-019-0227-4. Epub 2019 Feb 15.

PMID:
30770915
18.

Digital PCR in bone marrow trephine biopsies is highly sensitive for MYD88L265P detection in lymphomas with plasmacytic/plasmacytoid differentiation.

Willenbacher E, Willenbacher W, Wolf DG, Zelger B, Peschel I, Manzl C, Haun M, Brunner A.

Br J Haematol. 2019 Jul;186(1):189-191. doi: 10.1111/bjh.15792. Epub 2019 Feb 14. No abstract available.

PMID:
30763982
19.

MaxQuant.Live Enables Global Targeting of More Than 25,000 Peptides.

Wichmann C, Meier F, Virreira Winter S, Brunner AD, Cox J, Mann M.

Mol Cell Proteomics. 2019 May;18(5):982-994. doi: 10.1074/mcp.TIR118.001131. Epub 2019 Feb 12.

20.

RNA interference suppression of AGAMOUS and SEEDSTICK alters floral organ identity and impairs floral organ determinacy, ovule differentiation, and seed-hair development in Populus.

Lu H, Klocko AL, Brunner AM, Ma C, Magnuson AC, Howe GT, An X, Strauss SH.

New Phytol. 2019 Apr;222(2):923-937. doi: 10.1111/nph.15648. Epub 2019 Jan 19.

21.

NMR metabolomics of cerebrospinal fluid differentiates inflammatory diseases of the central nervous system.

French CD, Willoughby RE, Pan A, Wong SJ, Foley JF, Wheat LJ, Fernandez J, Encarnacion R, Ondrush JM, Fatteh N, Paez A, David D, Javaid W, Amzuta IG, Neilan AM, Robbins GK, Brunner AM, Hu WT, Mishchuk DO, Slupsky CM.

PLoS Negl Trop Dis. 2018 Dec 17;12(12):e0007045. doi: 10.1371/journal.pntd.0007045. eCollection 2018 Dec.

22.

Strategies for Engineering Reproductive Sterility in Plantation Forests.

Fritsche S, Klocko AL, Boron A, Brunner AM, Thorlby G.

Front Plant Sci. 2018 Nov 15;9:1671. doi: 10.3389/fpls.2018.01671. eCollection 2018.

23.

Isocitrate dehydrogenase 1 and 2 mutations, 2-hydroxyglutarate levels, and response to standard chemotherapy for patients with newly diagnosed acute myeloid leukemia.

Brunner AM, Neuberg DS, Wander SA, Sadrzadeh H, Ballen KK, Amrein PC, Attar E, Hobbs GS, Chen YB, Perry A, Connolly C, Joseph C, Burke M, Ramos A, Galinsky I, Yen K, Yang H, Straley K, Agresta S, Adamia S, Borger DR, Iafrate A, Graubert TA, Stone RM, Fathi AT.

Cancer. 2019 Feb 15;125(4):541-549. doi: 10.1002/cncr.31729. Epub 2018 Nov 13.

PMID:
30422308
24.

Online Parallel Accumulation-Serial Fragmentation (PASEF) with a Novel Trapped Ion Mobility Mass Spectrometer.

Meier F, Brunner AD, Koch S, Koch H, Lubeck M, Krause M, Goedecke N, Decker J, Kosinski T, Park MA, Bache N, Hoerning O, Cox J, Räther O, Mann M.

Mol Cell Proteomics. 2018 Dec;17(12):2534-2545. doi: 10.1074/mcp.TIR118.000900. Epub 2018 Nov 1.

25.

Prioritizing anthropogenic chemicals in drinking water and sources through combined use of mass spectrometry and ToxCast toxicity data.

Brunner AM, Dingemans MML, Baken KA, van Wezel AP.

J Hazard Mater. 2019 Feb 15;364:332-338. doi: 10.1016/j.jhazmat.2018.10.044. Epub 2018 Oct 18.

26.

Screw tip augmentation leads to improved primary stability in the minimally invasive treatment of displaced intra-articular fractures of the calcaneus: a biomechanical study.

Eichinger M, Brunner A, Stofferin H, Bölderl A, Blauth M, Schmölz W.

Int Orthop. 2019 Sep;43(9):2175-2181. doi: 10.1007/s00264-018-4171-9. Epub 2018 Oct 10.

PMID:
30306219
27.

Monitoring transformation product formation in the drinking water treatments rapid sand filtration and ozonation.

Brunner AM, Vughs D, Siegers W, Bertelkamp C, Hofman-Caris R, Kolkman A, Ter Laak T.

Chemosphere. 2019 Jan;214:801-811. doi: 10.1016/j.chemosphere.2018.09.140. Epub 2018 Sep 26.

28.

Results of universal ultrasound screening for developmental dysplasia of the hip: a prospective follow-up of 28 092 consecutive infants.

Biedermann R, Riccabona J, Giesinger JM, Brunner A, Liebensteiner M, Wansch J, Dammerer D, Nogler M.

Bone Joint J. 2018 Oct;100-B(10):1399-1404. doi: 10.1302/0301-620X.100B10.BJJ-2017-1539.R2.

PMID:
30295526
29.

Clustered incidence of adult acute promyelocytic leukemia.

Brunner AM, Kim PG, Sadrzadeh H, Drapkin BJ, Sprague KA, Sloan JM, Chai-Ho W, Bhargava P, Pozdnyakova O, Fathi AT.

Leuk Res. 2018 Nov;74:47-50. doi: 10.1016/j.leukres.2018.09.008. Epub 2018 Sep 19. No abstract available.

PMID:
30292128
30.

Low clinical trial accrual of patients with myelodysplastic syndromes: Causes and potential solutions.

Steensma DP, Brunner AM, DeZern AE, Garcia-Manero G, Komrokji RS, Odenike OS, Roboz GJ, Savona MR, Stone RM, Sekeres MA.

Cancer. 2018 Dec 15;124(24):4601-4609. doi: 10.1002/cncr.31769. Epub 2018 Oct 5.

PMID:
30289970
31.

Clinical infrared microscopic imaging: An overview.

Pallua JD, Brunner A, Zelger B, Stalder R, Unterberger SH, Schirmer M, Tappert MC.

Pathol Res Pract. 2018 Oct;214(10):1532-1538. doi: 10.1016/j.prp.2018.08.026. Epub 2018 Sep 4. Review.

PMID:
30220435
32.

Characteristics and Predictors for Secondary Leukemia and Myelodysplastic Syndrome in Ewing and Osteosarcoma Survivors.

Sanford NN, Miao R, Wang H, Goldberg S, Jacobson A, Brunner AM, Cote GM, Yock TI, Ebb DH, Chen YB, Jee KW, Hornicek F, DeLaney TF, Choy E, Chen YL.

Int J Radiat Oncol Biol Phys. 2019 Jan 1;103(1):52-61. doi: 10.1016/j.ijrobp.2018.08.037. Epub 2018 Aug 28.

PMID:
30165126
33.

Patient-Clinician Discordance in Perceptions of Treatment Risks and Benefits in Older Patients with Acute Myeloid Leukemia.

El-Jawahri A, Nelson-Lowe M, VanDusen H, Traeger L, Abel GA, Greer JA, Fathi A, Steensma DP, LeBlanc TW, Li Z, DeAngelo D, Wadleigh M, Hobbs G, Foster J, Brunner A, Amrein P, Stone RM, Temel JS.

Oncologist. 2019 Feb;24(2):247-254. doi: 10.1634/theoncologist.2018-0317. Epub 2018 Aug 23.

34.

Phenotypic Expression and Stability in a Large-Scale Field Study of Genetically Engineered Poplars Containing Sexual Containment Transgenes.

Klocko AL, Lu H, Magnuson A, Brunner AM, Ma C, Strauss SH.

Front Bioeng Biotechnol. 2018 Aug 3;6:100. doi: 10.3389/fbioe.2018.00100. eCollection 2018.

35.

The use of immunosuppressive therapy in MDS: clinical outcomes and their predictors in a large international patient cohort.

Stahl M, DeVeaux M, de Witte T, Neukirchen J, Sekeres MA, Brunner AM, Roboz GJ, Steensma DP, Bhatt VR, Platzbecker U, Cluzeau T, Prata PH, Itzykson R, Fenaux P, Fathi AT, Smith A, Germing U, Ritchie EK, Verma V, Nazha A, Maciejewski JP, Podoltsev NA, Prebet T, Santini V, Gore SD, Komrokji RS, Zeidan AM.

Blood Adv. 2018 Jul 24;2(14):1765-1772. doi: 10.1182/bloodadvances.2018019414.

36.

Impact of lenalidomide use among non-transfusion dependent patients with myelodysplastic syndromes.

Brunner AM, Weng S, Cronin A, Fathi AT, Habib AR, Stone R, Graubert T, Steensma DP, Abel GA.

Am J Hematol. 2018 Sep;93(9):1119-1126. doi: 10.1002/ajh.25166. Epub 2018 Aug 28.

37.

Repurposing an Old Drug for a New Epidemic: Ursodeoxycholic Acid to Prevent Recurrent Clostridioides difficile Infection.

Webb BJ, Brunner A, Lewis J, Ford CD, Lopansri BK.

Clin Infect Dis. 2019 Jan 18;68(3):498-500. doi: 10.1093/cid/ciy568.

PMID:
30020421
38.

Performance of the Medical Research Council (MRC) and the Leukemia Research Foundation (LRF) score in predicting survival benefit with hypomethylating agent use in patients with relapsed or refractory acute myeloid leukemia.

Stahl M, DeVeaux M, Montesinos P, Itzykson R, Ritchie EK, Sekeres MA, Barnard J, Podoltsev NA, Brunner A, Komrokji RS, Bhatt VR, Al-Kali A, Cluzeau T, Santini V, Roboz GJ, Fenaux P, Litzow M, Fathi AT, Perreault S, Kim TK, Prebet T, Vey N, Verma V, Germing U, Bergua J, Serrano J, Gore SD, Zeidan AM.

Leuk Lymphoma. 2019 Jan;60(1):246-249. doi: 10.1080/10428194.2018.1468893. Epub 2018 Jul 2. No abstract available.

PMID:
29963936
39.

Prognostic Value of Testing PD-L1 Expression After Radical Cystectomy in High-risk Patients.

Pichler R, Fritz J, Lackner F, Sprung S, Brunner A, Horninger W, Loidl W, Pircher A, Heidegger I.

Clin Genitourin Cancer. 2018 Oct;16(5):e1015-e1024. doi: 10.1016/j.clgc.2018.05.015. Epub 2018 Jun 8.

PMID:
29960831
40.

Reformulating acute myeloid leukemia: liposomal cytarabine and daunorubicin (CPX-351) as an emerging therapy for secondary AML.

Chen EC, Fathi AT, Brunner AM.

Onco Targets Ther. 2018 Jun 12;11:3425-3434. doi: 10.2147/OTT.S141212. eCollection 2018. Review.

41.

Incident adverse events following therapy for acute promyelocytic leukemia.

Kim PG, Bridgham K, Chen EC, Vidula MK, Pozdnyakova O, Brunner AM, Fathi AT.

Leuk Res Rep. 2018 May 5;9:79-83. doi: 10.1016/j.lrr.2018.05.001. eCollection 2018.

42.

Outcomes and predictors of survival in blast phase myeloproliferative neoplasms.

Lancman G, Brunner A, Hoffman R, Mascarenhas J, Hobbs G.

Leuk Res. 2018 Jul;70:49-55. doi: 10.1016/j.leukres.2018.05.004. Epub 2018 May 21.

PMID:
29807273
43.
44.

High NPM1-mutant allele burden at diagnosis predicts unfavorable outcomes in de novo AML.

Patel SS, Kuo FC, Gibson CJ, Steensma DP, Soiffer RJ, Alyea EP 3rd, Chen YA, Fathi AT, Graubert TA, Brunner AM, Wadleigh M, Stone RM, DeAngelo DJ, Nardi V, Hasserjian RP, Weinberg OK.

Blood. 2018 Jun 21;131(25):2816-2825. doi: 10.1182/blood-2018-01-828467. Epub 2018 May 3.

45.

Hypomethylating agents in relapsed and refractory AML: outcomes and their predictors in a large international patient cohort.

Stahl M, DeVeaux M, Montesinos P, Itzykson R, Ritchie EK, Sekeres MA, Barnard JD, Podoltsev NA, Brunner AM, Komrokji RS, Bhatt VR, Al-Kali A, Cluzeau T, Santini V, Fathi AT, Roboz GJ, Fenaux P, Litzow MR, Perreault S, Kim TK, Prebet T, Vey N, Verma V, Germing U, Bergua JM, Serrano J, Gore SD, Zeidan AM.

Blood Adv. 2018 Apr 24;2(8):923-932. doi: 10.1182/bloodadvances.2018016121.

46.

Allogeneic Hematopoietic Stem Cell Transplantation Following the Use of Hypomethylating Agents among Patients with Relapsed or Refractory AML: Findings from an International Retrospective Study.

Stahl M, DeVeaux M, Montesinos P, Itzykson R, Ritchie EK, Sekeres MA, Majhail N, Barnard J, Podoltsev NA, Brunner AM, Komrokji RS, Bhatt VR, Al-Kali A, Cluzeau T, Santini V, Roboz GJ, Fenaux P, Litzow M, Fathi AT, Perreault S, Kim TK, Prebet T, Vey N, Verma V, Kobbe G, Bergua J, Serrano J, Gore SD, Zeidan AM.

Biol Blood Marrow Transplant. 2018 Aug;24(8):1754-1758. doi: 10.1016/j.bbmt.2018.03.025. Epub 2018 Apr 9.

47.

High IDO-1 expression in tumor endothelial cells is associated with response to immunotherapy in metastatic renal cell carcinoma.

Seeber A, Klinglmair G, Fritz J, Steinkohl F, Zimmer KC, Aigner F, Horninger W, Gastl G, Zelger B, Brunner A, Pichler R.

Cancer Sci. 2018 May;109(5):1583-1591. doi: 10.1111/cas.13560. Epub 2018 Apr 16.

48.

No Mutation Left Behind: The Impact of Reporting Recurrent Genetic Abnormalities on Outcomes of Patients with Acute Myeloid Leukemia.

Brunner AM.

Acta Haematol. 2018;139(2):128-130. doi: 10.1159/000487071. Epub 2018 Feb 14. No abstract available.

49.

Secondary Acute Leukemia in Sarcoma Patients: A Population-Based Study.

Sanford NN, Martin AM, Brunner AM, Cote GM, Choy E, DeLaney TF, Aizer AA, Chen YL.

Int J Radiat Oncol Biol Phys. 2018 Mar 1;100(3):687-694. doi: 10.1016/j.ijrobp.2017.11.011. Epub 2017 Nov 14.

PMID:
29413281
50.

Prevalence of Cam and Pincer Deformities in the X-Rays of Asymptomatic Individuals.

Thier S, Gerisch D, Weiss C, Fickert S, Brunner A.

Biomed Res Int. 2017;2017:8562329. doi: 10.1155/2017/8562329. Epub 2017 Dec 18.

Supplemental Content

Loading ...
Support Center